血管生成因子与胎儿多普勒预测早发型小胎儿的围产结局
该回顾性研究纳入469例20+0至31+6周诊断的早发型小于胎龄儿或胎儿生长受限单胎妊娠,评估PlGF、sFlt-1/PlGF比值与胎儿多普勒单独及联合预测复合不良围产结局和后续子痫前期的效能。结果显示,PlGF联合胎儿多普勒对复合不良围产结局的AUC最高,但与PlGF单独预测无显著差异;sFlt-1/PlGF比值在预测后续子痫前期时效能最佳。
要点
- 早发型小胎儿中,PlGF单独预测复合不良围产结局效能与联合胎儿多普勒相当。
- sFlt-1/PlGF比值预测后续子痫前期AUC达0.861,优于其他标志物。
- 联合胎儿多普勒可降低假阳性率,但不能提高敏感性。
核心结论
- PlGF和sFlt-1/PlGF比值对早发型SGA/FGR的复合不良围产结局和子痫前期具有稳健的预测效能。
- PlGF和胎儿多普勒的预测价值不受子痫前期状态影响,而sFlt-1/PlGF比值在无子痫前期妊娠中预测准确性降低但仍优于多普勒。
研究设计与样本
- 回顾性观察性研究,2016年1月至2022年1月在西班牙巴塞罗那Vall d'Hebron大学医院开展。
- 纳入469例估计胎儿体重低于第10百分位、20+0至31+6周诊断为胎儿偏小的单胎妊娠。
- 入组时有胎儿多普勒超声数据和血管生成因子检测结果。
主要发现
- 复合不良围产结局总体发生率为46.5%。
- 全队列中PlGF联合胎儿多普勒预测复合不良围产结局的AUC为0.866(95%CI 0.833-0.899),高于胎儿多普勒单独预测。
- 联合模型与PlGF单独预测的AUC无显著差异(PlGF单独AUC 0.862,95%CI 0.828-0.895;P=0.621)。
- 无子痫前期妊娠中,PlGF是复合不良围产结局的最佳单一预测因子,AUC为0.797(95%CI 0.740-0.854)。
- 合并子痫前期的妊娠中,sFlt-1/PlGF比值是最佳单一预测因子,AUC为0.802(95%CI 0.728-0.876)。
关键数值与推荐
- 复合不良围产结局定义为至少符合以下一项:5分钟Apgar评分<7;脐动脉pH<7.0;新生儿重症监护室住院>48小时;死产;新生儿死亡;呼吸窘迫综合征;支气管肺发育不良;新生儿败血症;坏死性小肠结肠炎;III-IV级早产儿视网膜病变;III-IV级脑室内出血;或脑室周围白质软化。
- 入组时子痫前期已存在74/469例(15.8%),后续发展为子痫前期83例(17.7%)。
临床怎么用
- 支持将血管生成因子整合到早发型SGA/FGR的临床评估中,无论是否合并子痫前期。
- 联合胎儿多普勒与血管生成因子可降低假阳性率,有助于减少不必要的干预。
局限性
- 回顾性研究设计可能存在选择偏倚和信息偏倚。
- 单中心研究,结果的普遍适用性需多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the predictive performance of angiogenic factors and fetal Doppler, alone and in combination, for composite adverse perinatal outcome (CAPO) in early-onset small-for-gestational age (SGA) and fetal growth restriction (FGR), in cases both with and without pre-eclampsia (PE), in order to evaluate the ability of these markers to predict adverse outcomes beyond their established association with PE and to better delineate the specific contribution of PE to their predictive value. METHODS: This was a retrospective observational study conducted at Vall d'Hebron University Hospital, Barcelona, Spain, between January 2016 and January 2022. The study population included singleton pregnancies with an estimated fetal weight < 10th percentile, diagnosed with fetal smallness between 20 + 0 and 31 + 6 weeks' gestation, with fetal Doppler ultrasound data and available angiogenic factor measurements obtained at diagnosis. Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were measured at initial assessment. CAPO was defined as the presence of at least one of the following: 5-min Apgar score < 7; umbilical cord arterial pH < 7.0; admission to the neonatal intensive care unit for > 48 h; stillbirth; neonatal death; respiratory distress syndrome; bronchopulmonary dysplasia; neonatal sepsis; necrotizing enterocolitis; Grade-III-IV retinopathy of prematurity; Grade-III-IV intraventricular hemorrhage; or periventricular leukomalacia. Predictive performance for CAPO and subsequent PE was assessed using receiver-operating-characteristics (ROC)-curve analysis and area under the ROC curve (AUC) comparisons for fetal Doppler and angiogenic factors, alone and combined, within logistic regression models. Sensitivity, false-positive rate, positive predictive value and negative predictive value were calculated. All analyses were stratified according to PE development at any time before delivery. RESULTS: Overall, 469 women with an early-onset small fetus were included. PE was present at diagnosis in 74/469 (15.8%) cases and developed later in 83 (17.7%) cases. CAPO occurred in 46.5% of cases. In the overall cohort, PlGF combined with fetal Doppler findings showed the highest predictive performance for CAPO (AUC, 0.866 (95% CI, 0.833-0.899)), outperforming fetal Doppler alone. Notably, the performance of the combined model was not significantly different from PlGF alone (AUC, 0.862 (95% CI, 0.828-0.895); P = 0.621). These findings were consistent in pregnancies without PE, in which PlGF remained the best-performing single predictor of CAPO (AUC, 0.797 (95% CI, 0.740-0.854)). In pregnancies with PE at any time, the best-performing single predictor was the sFlt-1/PlGF ratio (AUC, 0.802 (95% CI, 0.728-0.876)). For the prediction of subsequent PE after enrolment, the sFlt-1/PlGF ratio alone (AUC, 0.861 (95% CI, 0.821-0.901)) and in combination with fetal Doppler (AUC, 0.862 (95% CI, 0.822-0.902)) achieved the highest predictive performance. Combining fetal Doppler findings with angiogenic factors reduced false-positive rates, but did not improve sensitivity. CONCLUSION: This study confirmed the robust predictive performance of PlGF and the sFlt-1/PlGF ratio for identifying CAPO and PE in early-onset SGA/FGR. The predictive value of PlGF and fetal Doppler remained consistent irrespective of PE status, while the sFlt-1/PlGF ratio showed reduced predictive accuracy in non-PE pregnancies, but still outperformed Doppler. These findings support the integration of angiogenic factors into the clinical assessment of early-onset SGA/FGR, for both cases with and those without PE. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Bonacina, Armengol-Alsina, Casellas, et al. Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early-onset small fetuses with and without pre-eclampsia. Ultrasound Obstet Gynecol. 2026. PMID: 41723869. doi:10.1002/uog.70188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。